Skip to content
Home/Companies/Pharma/Sobrera Pharma

Sobrera Pharma

Pharma·Sweden·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Sobrera Pharma?

Sobrera Pharma is currently owned by GU Ventures through GU Ventures Evergreen (1995 vintage), since 2019.

Hand-verified · updated 2026-08-17

GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorPharma
StatusActive

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Mucolife Therapeutics
Active
BiotechSweden· 2024
Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
SimSen Diagnostics
Active
MedTechSweden· 2020
Hydroc Energy Storage
Active
EnergySweden· 2019

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
Laboratoires Delbert
Active
SocadifFrance
Pharmathen
Active
Partners GroupGreece
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Biogaran
Biogaran
Active
Bpifrance InvestissementFrance· 2026
Track Sobrera Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Sobrera Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Sobrera Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue